Literature DB >> 25466768

The effects of North Carolina's prescription drug monitoring program on the prescribing behaviors of the state's providers.

Chris Ringwalt1, Mariana Garrettson, Apostolos Alexandridis.   

Abstract

State-level prescription drug monitoring programs (PDMPs) show promise as a key strategy to respond to the epidemic of the misuse and abuse of controlled substances (CS), particularly opioid analgesics, in the United States. Undocumented concerns have been expressed that these PDMPs may have a "chilling effect" on providers' willingness to prescribe these substances to their patients. Using data from North Carolina's PDMP for the 3-year period from 2009 through 2011, we examined whether rapid increases in (1) the number of providers who queried the system, and (2) the number of days on which they queried it, would be related to their prescribing practices in regards to CS. We hypothesized that neither marker of PDMP utilization would be associated with a decrease in either patients receiving CS prescriptions or CS prescriptions filled. We found no association between either of these variables and the number of patients who filled prescriptions for CS or the number of prescriptions for CS filled. However, we did find a slight positive relationship between the growth in the utilization of the PDMP and the number of prescriptions filled for opioid analgesics. Concerns that PDMPs may constrain prescribing behavior with regards to CS are not supported.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25466768     DOI: 10.1007/s10935-014-0381-0

Source DB:  PubMed          Journal:  J Prim Prev        ISSN: 0278-095X


  15 in total

Review 1.  Prescription drug monitoring programs, a response to doctor shopping: purpose, effectiveness, and directions for future research.

Authors:  Julie Worley
Journal:  Issues Ment Health Nurs       Date:  2012-05       Impact factor: 1.835

2.  Awareness and utilization of a prescription monitoring program among physicians.

Authors:  Lance Feldman; Kristi Skeel Williams; John Coates; Michele Knox
Journal:  J Pain Palliat Care Pharmacother       Date:  2011-09-21

3.  Medication reconciliation for controlled substances--an "ideal" prescription-drug monitoring program.

Authors:  Jeanmarie Perrone; Lewis S Nelson
Journal:  N Engl J Med       Date:  2012-05-30       Impact factor: 91.245

Review 4.  Prescription drug abuse: insight into the epidemic.

Authors:  S H Hernandez; L S Nelson
Journal:  Clin Pharmacol Ther       Date:  2010-08-04       Impact factor: 6.875

5.  The influence of prescription monitoring programs on chronic pain management.

Authors:  Jing Wang; Paul J Christo
Journal:  Pain Physician       Date:  2009 May-Jun       Impact factor: 4.965

Review 6.  Pain management and prescription monitoring.

Authors:  David E Joranson; Grant M Carrow; Karen M Ryan; Linda Schaefer; Aaron M Gilson; Patricia Good; John Eadie; Susan Peine; June L Dahl
Journal:  J Pain Symptom Manage       Date:  2002-03       Impact factor: 3.612

7.  Prescription drug monitoring programs and death rates from drug overdose.

Authors:  Leonard J Paulozzi; Edwin M Kilbourne; Hema A Desai
Journal:  Pain Med       Date:  2011-02-18       Impact factor: 3.750

Review 8.  Pain management: a fundamental human right.

Authors:  Frank Brennan; Daniel B Carr; Michael Cousins
Journal:  Anesth Analg       Date:  2007-07       Impact factor: 5.108

9.  State laws regulating prescribing of controlled substances: balancing the public health problems of chronic pain and prescription painkiller abuse and overdose.

Authors:  Andrea M Garcia
Journal:  J Law Med Ethics       Date:  2013-03       Impact factor: 1.718

10.  Prescription opioid usage and abuse relationships: an evaluation of state prescription drug monitoring program efficacy.

Authors:  Richard M Reisman; Pareen J Shenoy; Adam J Atherly; Christopher R Flowers
Journal:  Subst Abuse       Date:  2009-05-01
View more
  12 in total

1.  Emergency department utilization and subsequent prescription drug overdose death.

Authors:  Joanne E Brady; Charles J DiMaggio; Katherine M Keyes; John J Doyle; Lynne D Richardson; Guohua Li
Journal:  Ann Epidemiol       Date:  2015-04-02       Impact factor: 3.797

2.  The use of a prescription drug monitoring program to develop algorithms to identify providers with unusual prescribing practices for controlled substances.

Authors:  Christopher Ringwalt; Sharon Schiro; Meghan Shanahan; Scott Proescholdbell; Harold Meder; Anna Austin; Nidhi Sachdeva
Journal:  J Prim Prev       Date:  2015-10

3.  Systematic Literature Review of Prescription Drug Monitoring Programs.

Authors:  Aditya Ponnapalli; Adela Grando; Anita Murcko; Pete Wertheim
Journal:  AMIA Annu Symp Proc       Date:  2018-12-05

Review 4.  The Association of State Opioid Misuse Prevention Policies With Patient- and Provider-Related Outcomes: A Scoping Review.

Authors:  Amanda I Mauri; Tarlise N Townsend; Rebecca L Haffajee
Journal:  Milbank Q       Date:  2019-12-04       Impact factor: 4.911

5.  Effect of a "pill mill" law on opioid prescribing and utilization: The case of Texas.

Authors:  Tatyana Lyapustina; Lainie Rutkow; Hsien-Yen Chang; Matthew Daubresse; Alim F Ramji; Mark Faul; Elizabeth A Stuart; G Caleb Alexander
Journal:  Drug Alcohol Depend       Date:  2015-12-31       Impact factor: 4.492

6.  Prescription drug abuse communication: A qualitative analysis of prescriber and pharmacist perceptions and behaviors.

Authors:  Nicholas E Hagemeier; Fred Tudiver; Scott Brewster; Elizabeth J Hagy; Angela Hagaman; Robert P Pack
Journal:  Res Social Adm Pharm       Date:  2015-12-29

7.  Mandatory review of a prescription drug monitoring program and impact on opioid and benzodiazepine dispensing.

Authors:  Erin L Winstanley; Yifan Zhang; Rebecca Mashni; Sydney Schnee; Jonathan Penm; Jill Boone; Cameron McNamee; Neil J MacKinnon
Journal:  Drug Alcohol Depend       Date:  2018-05-01       Impact factor: 4.492

8.  Prescription monitoring programs and emergency department visits involving opioids, 2004-2011.

Authors:  Brandon C Maughan; Marcus A Bachhuber; Nandita Mitra; Joanna L Starrels
Journal:  Drug Alcohol Depend       Date:  2015-09-30       Impact factor: 4.492

9.  The Changed Injury Landscape, More on Injury Prevention Roles for the Lifestyle Physician, and More Than "Limited Progress" Since Injury in America.

Authors:  Herbert I Linn
Journal:  Am J Lifestyle Med       Date:  2016-01-13

10.  Characteristics and Red Flag Correlates of Psychiatric Outpatients in a Mandated-Use Prescription Drug Monitoring Program State: A PBRN Card Study.

Authors:  Andrew W Hunt; Kathleen Clegg; Christina Delos Reyes; Maureen Riley-Behringer; Stephen Zyzanski; James Werner
Journal:  Addict Disord Their Treat       Date:  2019-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.